Blenrep for Multiple Myeloma Withdrawn From US Market ...Middle East

Medscape - News
The manufacturer is pulling the drug from the market at the request of the FDA following disappointing results from a large phase 3 confirmatory trial. News Alerts

Hence then, the article about blenrep for multiple myeloma withdrawn from us market was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Blenrep for Multiple Myeloma Withdrawn From US Market )

Apple Storegoogle play

Last updated :

Also on site :